At GENESIS Pharma, we have dedicated over twenty years to investing in an extensive social contribution program.
Central to this program is our support to Patient Associations for chronic and rare diseases and charitable organizations assisting patients. Throughout these years, we have been consistently supporting numerous Patient Associations with respect to their work, aiming to assist them in seamlessly delivering their services to patients.
Equally vital for us is our commitment to public awareness initiatives and campaigns for health and prevention issues. Thus, we have been implementing awareness activities for diseases such as multiple sclerosis, cancer, rare genetic diseases, and more.
Over the past years, we have significantly strengthened our investment in solidarity actions focused on special social needs. Our company has been actively participating in the 'DIATROFI (Nutrition)' Program, implemented by the Prolepsis Institute to address children's food insecurity. Through 'DIATROFI', we have provided 59,000 healthy meals to over 800 children in 16 schools over the past years.
Our employees also contribute significantly to our company's social initiatives through the voluntary team GENEROUS, created to support NGOs and institutions in need. Finally, at GENESIS Pharma, we have also formed a running team that participates in sports events to support causes of Patient Associations and NGOs.
Since 2021, GENESIS Pharma has also been included in ‘The Most Sustainable Companies in Greece’ annual ranking by the QualityNet Foundation. This recognition follows an evaluation based on the Sustainability Performance Directory Business Index, aligning with the specifications of the Greek Sustainability Code and ESG criteria.
Finally, as members of CSR Hellas, we actively participate in The Hellenic Pact for Sustainable Industry (P4SI-EL).